Categories
World Headlines

Gilead says late-stage remdesivir trial shows improvement in some coronavirus patients

Gilead Sciences shares fell after results from a phase 3 trial showed its antiviral drug remdesivir helped some patients with moderate Covid-19.

  1. Gilead says late-stage remdesivir trial shows improvement in some coronavirus patients  CNBC
  2. Gilead’s stock falls on remdesivir data in moderately ill patients  MarketWatch
  3. Gilead’s remdesivir shows some benefit in patients with moderate Covid-19  STAT
  4. Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19  Business Wire
  5. Gilead says remdesivir helped moderate coronavirus patients improve  Fox Business